-
Recent Posts
- Camtek Ltd. (NASDAQ: CAMT) Shares Climb After First Quarter Growth and Positive Outlook
- Is There Hope for Next Generation Corp. (OTCQB: NGMC) in Oil and Gas Industry?
- Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Spikes with Promise of Tasimelteon
- Is Enviro-Serv, Inc. (PINKSHEETS: EVSV) Any Closer to Generating Revenues?
- Eagle Bulk Shipping, Inc. (NASDAQ: EGLE) Spikes on Earnings but is there More to the Numbers?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: biopharma
Genta, Inc. (OTCBB: GNTA) Releases Positive News About Breast Cancer Treatment, FDA Meeting to Outline Phase 3 Study Could be in Near Future
Shares of Genta, Inc. (OTCBB: GNTA) skyrocketed on Thursday, closing the day up more than 161% with staggering trading volume that exceeded 439 million following the biopharmaceutical company’s announced results from their Phase 2b clinical trial using tesetaxel as initial, … Continue reading
Posted in Uncategorized
Tagged biopharma, breat cancer, cancer, chemotherapy, fda, genta, gnta, investors, otcbb, penny stocks, taxane, tesetaxel
Leave a comment
MultiCell Technologies (OTCBB: MCET) has Value in Patents but can Clinical Stage Company Overcome Financial Mess
While it has been less than three months since MultiCell Technologies (OTCBB: MCET) shot to a 52-week high of 0.0245 following news that they had been awarded U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating … Continue reading
Posted in Articles, OTC Bulletin Board, Penny Stocks
Tagged biopharma, investors, liver stem cells, mcet, multicell technologies, otcbb, patents, penny stocks, stem cells
Leave a comment


